STOK - Stoke Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

STOK is currently covered by 7 analysts with an average price target of $26.7. This is a potential upside of $13.45 (101.51%) from yesterday's end of day stock price of $13.25.

Stoke Therapeutics's activity chart (see below) currently has 71 price targets and 80 ratings on display. The stock rating distribution of STOK is 96.55% BUY and 3.45% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.14% with an average time for these price targets to be met of 114.42 days.

Highest price target for STOK is $35, Lowest price target is $22, average price target is $21.4.

Most recent stock forecast was given by JOSEPH STRINGER from NEEDHAM on 01-Jul-2025. First documented stock forecast 15-Jul-2019.

Currently out of the existing stock ratings of STOK, 28 are a BUY (96.55%), 1 are a HOLD (3.45%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$22

$9.15 (71.21%)

$22

1 months 7 days ago
(01-Jul-2025)

5/22 (22.73%)

$10.35 (88.84%)

48

Buy

$35

$22.15 (172.37%)

$47

2 months 25 days ago
(14-May-2025)

0/11 (0%)

$26.01 (289.32%)

Buy

7 months 29 days ago
(10-Dec-2024)

1/5 (20%)

$8.45 (152.25%)

232

Buy

$17

$4.15 (32.30%)

$17

1 years 28 days ago
(11-Jul-2024)

2/6 (33.33%)

$2.97 (21.17%)

60

Buy

$20

$7.15 (55.64%)

$21

1 years 3 months 1 days ago
(07-May-2024)

0/3 (0%)

$8.06 (67.50%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is STOK (Stoke Therapeutics) average time for price targets to be met?

On average it took 114.42 days on average for the stock forecasts to be realized with a an average price target met ratio 33.14

Which analyst has the current highest performing score on STOK (Stoke Therapeutics) with a proven track record?

ALETHIA YOUNG

Which analyst has the most public recommendations on STOK (Stoke Therapeutics)?

Alethia Young works at CANTOR FITZGERALD and has 5 price targets and 5 ratings on STOK

Which analyst is the currently most bullish on STOK (Stoke Therapeutics)?

Michelle Gilson with highest potential upside - $64.15

Which analyst is the currently most reserved on STOK (Stoke Therapeutics)?

Greg Harrison with lowest potential downside - -$0.85

Stoke Therapeutics in the News

CG Oncology, Inc. (CGON) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

CG Oncology, Inc. (CGON) is expected to deliver flat earnings compared to the year-ago quarter on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a good sense of the company’s earnings picture, but how the actual results compare to these estimates is a powerful factor that...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?